002422 科倫藥業
按盤價 
31.110 +1.710 (+5.816%)
31.110 +1.710 (+5.816%) | 2024/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 6,219,417 | 10.32% | 21,453,929 | 19,038,216 | 17,277,408 | 16,464,201 | |
| 減：營業總成本 | 4,767,843 | 2.42% | 18,277,363 | 17,223,484 | 16,290,481 | 15,745,366 | |
| 其中:營業成本 | 2,746,624 | 7.68% | 10,205,535 | 9,040,158 | 7,660,152 | 7,532,912 | |
| 財務費用 | 16,831 | -82.43% | 233,761 | 479,834 | 505,647 | 592,380 | |
| 資產減值損失 | 0 | -100.00% | (130,551) | (44,113) | (50,428) | (57,488) | |
| 公允價值變動收益 | 2,939 | 99.02% | 14,666 | 9,861 | 4,828 | 421 | |
| 投資收益 | 111,835 | 25.29% | 358,882 | 234,580 | 214,829 | 94,825 | |
| 其中：對聯營企業和合營企業的投資收益 | 112,558 | -50.67% | 352,105 | 228,194 | 127,303 | 86,832 | |
| 營業利潤 | 1,632,448 | 44.77% | 3,654,143 | 2,195,142 | 1,319,843 | 1,009,962 | |
| 利潤總額 | 1,624,795 | 45.65% | 3,580,426 | 2,067,919 | 1,177,616 | 955,031 | |
| 減：所得稅費用 | 338,994 | 118.01% | 933,787 | 363,697 | 309,499 | 163,554 | |
| 淨利潤 | 1,285,801 | 33.93% | 2,646,639 | 1,704,221 | 868,117 | 791,477 | |
| 減：非控股權益 | 259,613 | 78.28% | 190,527 | (1,103) | (234,438) | (37,909) | |
| 股東淨利潤 | 1,026,188 | 26.00% | 2,456,112 | 1,705,324 | 1,102,554 | 829,386 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.670 | 17.54% | 1.690 | 1.220 | 0.780 | 0.580 | |
| 每股派息 (元) * | -- | -- | 0.800 | 0.616 | 0.426 | 0.319 | |
| 每股淨資產 (元) * | 13.899 | 25.40% | 13.009 | 10.864 | 9.721 | 9.383 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | -- | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 05/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
